DiagnoCure
  • Français
  • Site Map
  • Glossary
  • Contact Us
  • Home
  • About DiagnoCure
    • Mission and History
    • Board of Directors
    • Management
    • Advisory Board
    • Intellectual Property
  • Investors
    • Overview
    • Q&A
    • Financial Information
    • Press Releases
    • Strategy
    • Management
    • Presentations
    • Analysts
    • Corporate Governance
    • Investors Contact
  • News and Events
    • Overview
    • Press Releases
    • Events
    • News Alerts
    • Media Room
  • Products and Projects
    • Overview
    • Highlights on Cancer
    • Molecular Diagnostics
    • Prostate Cancer
    • Colorectal Cancer
    • Breast Cancer
    • Bladder Cancer
    • Other R&D Projects
    • Useful Links
  • Customer Service
  • Career
    • A Career of Passion
    • Talent Wanted
  • Overview
  • Q&A
  • Financial Information
  • Press Releases
  • Strategy
  • Management
  • Presentations
  • Analysts
  • Corporate Governance
  • Investors Contact
  • News Alert

Presentations

Date Title / Event
2010-03-18 Webcast - Q1 financial results Presentation
2010-01-14 Corporate Presentation
2009-10-07 BioContact presentation
2009-04-29 BioFinance presentation
2008-10-06 Webcast - Third annual JMP Securities Healthcare Focus Conference
2007-08-16 DiagnoCure acquires new high-value diagnostic tests for breast and colon cancer
2007-05-02 DiagnoCure acquires exclusive worldwide rights to gene-based tests for colorectal cancer

2050 René-Lévesque Blvd W., 6th floor, Québec QC G1V 2K8 CAN

T: (418) 527-6100   F: (418) 527-0240   Toll-free: 1-888-900-6626 (Canada and USA)   communications@diagnocure.com

Terms of Use